Sie sind auf Seite 1von 7

Drug Injection Devices to 2020

Devices, Products, Markets, Strategies & Forecasts





June 2014

Report Prospectus
Life Science Technology Practice
A Comprehensive Report


Greystone Research Associates is pleased to announce the publication of a new market
study. Drug Injection Devices to 2020: Devices, Products, Markets, Strategies and
Forecasts is a comprehensive evaluation and analysis of the technology, products and
participants providing the driving force behind this evolving segment of the healthcare
sector.

The study is designed to provide drug company decision makers, drug delivery
developers, device designers, healthcare marketers, and supply chain participants with a
detailed understanding of the economics, technologies, drug classes, disease segments,
and product selection criteria for drug injection devices. Provider organization business
managers, healthcare administrators and investors will also benefit from this study.

The Evolving Landscape for Injectable Drugs
As new drugs become available for the treatment of an expanding list of health
conditions, drug developers have increasingly pursued packaging and delivery options
that simplify the administration process and increase the efficiency and reliability with
which the drug can be introduced into the patient. For injectable drugs, this pursuit has
led to an accelerated evolution in injection device design, creating new opportunities
and choices for drug designers and marketers. The injectable device sector today
consists of a half-dozen established device classes and two emerging classes. For the
remainder of the decade, pipeline drugs and shifting demographics will drive sector
growth as an aging population of baby boomers (23% of U.S. population) provides
stimulus for industry demand. Currently, the over 65 segment accounts for
approximately 13% of the U.S. population, with an estimated 40% of total healthcare
expenditures, but by 2020, this segment is expected to grow to 17% of the population.
This aging of the population will predominately benefit products that can be used by the
elderly.

Report Value Chain Who Should Read This Report

Development
Drug Developers
Device Suppliers
CMOs
Components/APIs
Testing/Validation
Clinical Trial Mgmt

Industry
Pharma Managers
Biotech Managers
Drug Marketers
Industry Strategists
Financial Analysts
Management Consultants
Market
Clinical Managers
Drug Distributors
Pharma Regulators
FDA Consultants
Managed Care Managers


D
r
u
g

I
n
j
e
c
t
i
o
n

D
e
v
i
c
e
s

t
o

2
0
2
0



Executive Summary
Drug Injection Device Market Dynamics
Evolution in Injectable Drug Development
Injectable Drug Demand Drivers
Diseases and Indications
Syringe Economics
Chronic Conditions & Self-Administration
Technology Factors
Device Selection Factors
Market Segmentation
Product Features & Ease of Use
Competitive Landscape
Injection Device Suppliers
Capabilities and Market Presence
Technology and Infrastructure
Market Success Factors
Injection Devices
Autoinjectors
Dual Chamber Syringes
Needle-free Injectors
Pen Injectors
Prefilled Syringes
Safety Syringes
Emerging Device Classes
Wearable Injectors
Patch Pumps
Large Volume wearable Injectors
Risks and Opportunities
Injection Device Selection Criteria
Stability and Material Selection Issues
Single vs Multi-Dose Devices
Fixed vs Variable Dose Devices
Lyophilized Drugs/Reconstitution
Syringe Safety/Sharps Protection
Needle Configuration Strategies
Disposable Drug Cartridges
Human Engineering/Ergonomics
Branding/Private Labeling
Drug Delivery Devices Device Classes and Analysis
Autoinjectors
Autoinjector Device Categories
Reusable Autoinjectors
Disposable Autoinjectors
Product Specific Autoinjectors
Autoinjector-specific Selection Factors
Safety Features
Needle Shielding
Needle Insertion Depth
Failsafe Activation
Dose Inspection/Injection Confirmation
Device Evolution and Market Impact
Dual Chamber Syringes
Needle-free Injectors
Device Categories
End User/Practitioner/Mass Immunization Injectors
Prefilled Disposable Models
Refillable Cartridge Designs
Needle-free Injector-specific Selection Factors
Table of Contents


Energy Source/Injection Site Selection
Injection Site Selection
Needle-free Injectors the Next Six Years
Pen Injectors
Recent Segment Evolution and Product Consolidation
Pen Design and Device Selection
Standardized Pen Platforms
Custom Pen Designs
Pen Classes
Reusable Pens
Disposable Pens
Dual Chamber Pens
Pen Injector Evolution the Picture in 2020
Prefilled Syringes
Prefilled Syringe Device Categories
Glass Prefilled Syringes
Plastic Prefilled Syringes
Prefillable Safety Syringes
Prefilled Syringe Selection Factors
Ready to Fill Prefillable Syringes
Fill-and-Finish CSO Selection
PFS Trending and Evolution the Next Six Years
Safety Syringes
Safety Syringe Device Categories
Integrated Safety Syringes
Automatic Safety Mechanism
Manual Safety Mechanism
Post Manufacture Add-on/Bolt-on Safety Mechanisms
Safety Syringes Market Evolution and Segment Expectations
Wearable Injectors
Patch Pumps
Large Volume Wearable Injectors
Drug Injection Device Market Segment Analysis & Forecasts
Anaphylaxis
Anticoagulants
Antivirals
Autoimmune Diseases
Diabetes
Emergency Medicine
Hematopoietics
Hormone Replacement
Neurology
Osteoporosis
Reproductive Health
Vaccines
Injectable Drug Therapeutics - Market Factors
Regulatory Factors and Issues
FDA Regulations
Regulating Combination Products
Sharps Legislations
Growth and Diversity of Safety Syringes
Sharps Disposal
Managed Care and Healthcare Economics
Company Profiles




Go to http://www.greystoneassociates.org/Drug_Delivery.htm for more information





Detailed Quantitative Market Data
Over 80 Charts & Tables
Go to http://www.greystoneassociates.org/Drug_Delivery.htm for more information



What You Will Learn

Analyzes and evaluates the shifting landscape for injectable drug delivery and assesses the market impact
of new and evolving syringes and injectors therapeutic indication
Assesses syringe and injector device designs, feature/functionality, product branding, competing
technologies and market development issues
Provides detailed descriptions of key injection device market segments, market demographics, and
business strategies
Forecasts syringe and injector demand by indication and therapy to 2020
Profiles leading injection device companies, their product development activities, business strategies, and
corporate alliances and affiliations
Evaluates the impact of economic, technology, and regulatory factors on injectable drug delivery demand

Report Format and Availability


This report is available electronic format. A site license for a single physical location and a corporate license
are also available. Custom licensing options to address specific company user requirements are available by
calling client services at 603-595-4340, or by emailing clientservices@greystoneassociates.org.


Methodology


Research methodology is based on primary research in the form of in-depth interviews with key market
participants, technology developers, distributors, industry experts, and market influencers, a list that includes
regulatory officials, industry trade groups, and materials standards organizations.
Primary data is evaluated and normalized against secondary sources including trade journal articles, technical
literature, industry publications, company data sheets and published information, and statistical data from
government agencies and trade associations.
Forecasts and projections of market demand and future market activity are derived using standard modeling
and statistical techniques.

About Greystone Associates


Greystone Associates is a medical technology consulting firm focused on the areas of medical market strategy,
product commercialization, venture development, and market research. We assist medical and healthcare
market participants in achieving their business objectives through the creation of detailed development
strategies, product commercialization programs, and comprehensive market and technology research and
analysis.

Our market research publications are designed, researched and written to provide timely and insightful
information and data on focused market segments, with the aim of providing market participants with the
essential knowledge to refine and execute their marketing plans and financial targets.
Comprehensive Assessments & Forecasts
Go to http://www.greystoneassociates.org/Drug_Delivery.htm for more information


Ordering Information

Orders may be placed via postal mail, e-mail or fax. Orders not accompanied by a purchase order must contain a
telephone number for verification, and clearly indicate the physical shipping address. Orders which are not prepaid must
indicate the billing address. There is no charge for handling and shipping for destination addresses within the continental US.
Payment
We accept the following forms of payment:
Company Check: Please make checks payable to Greystone Associates
Credit Cards: We accept MasterCard, Visa and American Express
Wire Transfers: See Wire Transfers below for more information
Orders Outside the U.S.
Orders must be prepaid via credit card, company check in US funds and drawn on a US bank, or wire transfer. There is a $50
per copy shipping and handling charge for international shipments.

Wire Transfers:
TD Banknorth
300 Franklin Street
Manchester, NH 03103
(Call for Account Information)
Mailing Address:
Greystone Research Associates
Client Services
P.O. Box 1362
Amherst, NH 03031














98 Route 101A P .O. Box 1362 Amherst, NH 03031 603-595-4340 (F) 603-218-7020 reports@greystoneassociates.org

Drug Injection Devices to 2020
Devices, Products, Markets, Strategies & Forecasts
Select Format Price (U.S. funds) Total

Electronic $4,850.00


Site License $7,500.00


Enterprise License $9,500.00

Total Payment (U.S. funds)
Method of Payment: ___ Company Check ___ ___ ___ ___ Wire Transfer
(International)
Card Number:___________________________ Name on Card ________________________________________

Expiration Date: ____________ Card CVV_______ Signature___________________________________

Billing Information Shipping Information
Click here if same as Billing Information
Name: Name:
Title: Title:
Company: Company:
Street Address: Street Address:
City,State/Province: City,State/Province:
Country/Postal Code: Country/Postal Code:
Phone: Phone:
Fax: Fax:
Email: Email:





How To Order
Fax to:
603-218-7020
or email to
clientservices@greystoneassociates.org

Das könnte Ihnen auch gefallen